![Jolanta Airey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Dr. Jolanta Airey is a Chief Medical Officer at Cynata Therapeutics Ltd. Dr. Airey was previously employed as a Director-Translational Development by CSL Ltd. and a Head-Clinical Development Physician by Csl Seqirus.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/06/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CYNATA THERAPEUTICS LIMITED | Direttore Tecnico/Scientifico/R&S | 11/10/2021 |
| Società | Posizione | Fine |
|---|---|---|
| CSL LIMITED | Corporate Officer/Principal | 01/10/2021 |
Csl Seqirus | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Cynata Therapeutics Ltd.
 Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services | Health Technology |
Csl Seqirus | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
